Latest news
Claims Data Lend Support to Tirzepatide’s CV Effects in Patients With Diabetes - TCTMD.comTCTMD.com · Fri, 07 Aug 2026 18:12:28 GMTThe Oral GLP-1 Tracker: Lilly's Foundayo builds scripts after disappointing Q2 - Fierce PharmaFierce Pharma · Fri, 07 Aug 2026 07:00:00 GMTObesity | Pros, Cons, Debate, Arguments, BMI, Disease & Health - Encyclopedia BritannicaEncyclopedia Britannica · Fri, 07 Aug 2026 05:00:00 GMTHow Investors May Respond To Rhythm Pharmaceuticals (RYTM) Q2 Results And Early RM-718 Obesity Data - simplywall.stsimplywall.st · Thu, 06 Aug 2026 20:48:45 GMTObesity in India - Data For IndiaData For India · Tue, 04 Aug 2026 21:15:56 GMTMeasuring obesity in India - Data For IndiaData For India · Tue, 04 Aug 2026 17:19:10 GMTPfizer axes ex-Metsera obesity asset and GIPR prospect in quarterly clearout - Fierce BiotechFierce Biotech · Tue, 04 Aug 2026 12:47:33 GMTRhythm Pharmaceuticals Announces Preliminary Data from - GlobeNewswireGlobeNewswire · Tue, 04 Aug 2026 10:55:00 GMT